Sandoz International GmbH

Related Content

Sandoz and Teva achieve independent certification for steps to minimise antimicrobial resistance risk

Sandoz opens new packaging centre in Stryków, Poland

Nick Haggar of Sandoz to become new EGA President

Asia and Latin America will drive biosimilars growth in next decade, says Visiongain

Sandoz begins clinical trial of biosimilar rituximab

FDA approves first generic version of Lovenox

Sandoz to acquire Oriel Therapeutics

Biosimilars poised for market impact

Somatropin launch paves way for entry of biosimilars in Japan

Sandoz launches Prograf generic capsules in US

Sandoz receives approval for first Japanese biosimilar

Sandoz receives EC approval for biosimilar filgrastim